c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Inhibrx (INBX) Unveils Promising Phase 1/2 Data for Ozekibart in Ewing Sarcoma
GuruFocus | Nov 17, 2026 5:51 PM EST
Related Stocks: INBX ,
Read original article